SC
TEAR

Sophrosyne Capital’s TearLab Corporation TEAR Stock Holding History

Sophrosyne Capital’s Portfolio TEAR Stock Details TEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,280
Closed -$136K – 75
2013
Q2 		$136K Buy
+1,280
New +$117K 0.11% 49

Other funds holding TEAR

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sophrosyne Capital's TEAR Position: Q3 2013 in Review

Sophrosyne Capital sold out of TearLab Corporation (TEAR) in Q3 2013, closing a stake of 1,280 shares — an estimated $136K sold.

Sophrosyne Capital first reported a position in TEAR in Q2 2013 and held it in 1 quarter. The position peaked at $136K in Q2 2013. 90 funds tracked by Wall St. Rank hold TEAR as of Q3 2013.

  • Sophrosyne Capital reported no remaining TearLab Corporation position as of Q3 2013 after selling out during the quarter.
  • Sophrosyne Capital sold 1,280 TearLab Corporation shares in Q3 2013, an estimated $136K.
  • Sophrosyne Capital first reported a position in TearLab Corporation in Q2 2013 and held it in 1 quarter.
  • Sophrosyne Capital's TearLab Corporation position peaked at $136K in Q2 2013.
  • 90 funds tracked by Wall St. Rank held TearLab Corporation as of Q3 2013.

Based on Sophrosyne Capital's 13F filing for Q3 2013, filed 14 Nov 2013.